COFEPRIS
- Status: likely_approved
BNT162b2 Bivalent (original/Omicron BA.4/BA.5) 30 mcg (bnt162b2-bivalent-original-omicron-ba-4-ba-5-30-mcg) regulatory status in Mexico.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. COFEPRIS has authorised it.
Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.